Tag Archives: ASX

Zelda Announces Priority Share Offer for CannPal Animal Therapeutics IPO Shares

Zelda Joins with US Children’s Hospital to Study Cannabinoid Treatment in Autism

Zelda Joins with US Children’s Hospital to Study Cannabinoid Treatment in Autism

PERTH, Australia, Dec. 11, 2017 /Weed Wire/ — The Board of Zelda Therapeutics Ltd (ASX: ZLD, Zelda or the Company) is pleased to announce it has entered into a research agreement with Children’s Hospital of Philadelphia (CHOP) to study the pharmacology of cannabinoids.

DayaCann AusCann Group Holdings - Medical Liaison Managers placement Tasmanian Alkaloids and Chilean License

Chilean Cultivation Licence Secured for Second Crop

CARABOODA, Western Australia, Nov. 22, 2017 /Weed Wire/ — AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) is pleased to announce that its joint venture (JV) in Chile, DayaCann, has secured a further licence for the cultivation of medical cannabis crops at its Chilean facility.

THC

Major Israeli Medicinal Cannabis company BOL Pharma partners with THC in Australia

SYDNEY, Australia, Nov. 20, 2017 /Weed Wire/ — The Hydroponics Company Limited (ASX:THC) (“THC”) is pleased to announce that its wholly owned subsidiary Canndeo Limited has entered into a Letter of Intent (LOI) with leading Israeli medicinal cannabis group BOL Pharma Limited (BOL) for the supply of cannabinoid related products in Australia.

THC

THC Signs Medicinal Cannabis Distribution Agreement with Major European Distributor, Endoca

SYDNEY, Australia, Nov. 15, 2017 /Weed Wire/ — The Hydroponics Company Limited (ASX:THC) (“THC” or “the Company”) is pleased to announce that its wholly-owned subsidiary Canndeo Limited has signed a distribution agreement with Endoca, a European provider of high quality pharmaceutical grade medicinal cannabis, to distribute medicinal cannabis products into Australia.

DayaCann AusCann Group Holdings - Medical Liaison Managers placement Tasmanian Alkaloids and Chilean License

AusCann: Medical Liason Managers Appointed

CARABOODA, Western Australia, Sept. 14, 2017 /Weed Wire/ — AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) is pleased to announce it has appointed three Medical Liaison Managers (MLMs), to manage doctor communications and assist in the prescription of AusCann’s cannabinoid medicines in Australia.

THC

Sinapse Partnership to Facilitate Prescribing and Dispensing of Medicinal Cannabis in Australia

SYDNEY, Australia, Sept. 1, 2017 /Weed Wire/ – The Hydroponics Company Limited (ASX: THC) is pleased to announce the first partnership with Sinapse Pty Ltd (Sinapse) as a key partner in its strategy to facilitate medicinal cannabis prescribing and dispensing in Australia.

Zelda Announces Priority Share Offer for CannPal Animal Therapeutics IPO Shares

Zelda Announces Priority Share Offer for CannPal Animal Therapeutics IPO Shares

The Board of Zelda Therapeutics Ltd is pleased to announce that its shareholders are invited to participate as a priority applicant in the prospectus capital raising of CannPal Animal Therapeutics Limited (CannPal) lodged with the ASIC.

Zelda Therapeutics Research Programme Zelda autism Research Collaboration

Zelda Expands Its Breast Cancer Research Collaboration with Complutense University Madrid

PERTH, Australia, July 31, 2017 /Weed Wire/ — The Board of Zelda Therapeutics Ltd (ASX: ZLD, Zelda or the Company) is pleased to announce it has expanded its research collaboration with Complutense University.

DayaCann AusCann Group Holdings - Medical Liaison Managers placement Tasmanian Alkaloids and Chilean License

AusCann – Tasmanian Alkaloids Licences Secured

CARABOODA, Western Australia, July 11, 2017 /Weed Wire/ — AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) is pleased to announce its strategic partner Tasmanian Alkaloids Pty Ltd has been granted a medicinal cannabis licence and a research and development licence from the Office of Drug Control.

THC

ASX Medicinal Cannabis Company Signs Exclusive Strategic Alliance with US-Based Pharmaceutical Company

SYDNEY, Australia, May 24, 2017 /Weed Wire/ — The Hydroponics Company Limited (ASX:THC) (“THC” or “the Company”) is pleased to announce that it has signed an exclusive Strategic Alliance with Colorado-based healthcare solutions company Phoenix Life Sciences Inc (“Phoenix Life”) to collaboratively research, develop, manufacture, distribute and sell medicinal cannabis products in Australia and internationally.

DayaCann AusCann Group Holdings - Medical Liaison Managers placement Tasmanian Alkaloids and Chilean License

AusCann Secures $12 million in Institutional Placement

CARABOODA, Western Australia, May 19, 2017 /Weed Wire/ – AusCann Group Holdings Ltd (ASX:AC8 or “the Company”) is pleased to announce it has successfully raised $12 million (before capital raising costs) via a Placement to institutional and high net worth investors.

THC

THC:ASX Announcement: 1st Quarter Revenue up 22% And US Expansion

SYDNEY, Australia, May 9, 2017 /Weed Wire/ – The Hydroponics Company Limited (ASX: THC) is pleased to announce that first quarter revenue in its wholly owned subsidiary CMDV (Crystal Mountain (Canada)/Dragon Vision (Hong Kong)) increased by more than 22% year-on-year to over $1.11m.

THC

ASX:THC Commences Trading on the Australian Securities Exchange

SYDNEY, Australia, May 4, 2017 /Weed Wire/ — The Hydroponics Company Limited (ASX:THC or ‘the Company’) is pleased to announce that it has today commenced trading on the Australian Securities Exchange (ASX), following its successful $8m capital raising. The Company is well placed to achieve a number of milestones in the next 6-12 months.

AusCann

AusCann Group Provides Quarterly Overview

CARABOODA, Western Australia, April 28, 2017 /Weed Wire/ — AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) has today announced its appendix 4C for the 3 month period ended 31 March 2017 and is pleased to provide an overview of its activities for the quarter.

Australian Company Harvesting Medical Cannabis Crop in Chile

Australian Company Harvesting Medical Cannabis Crop in Chile

On April 10, 2017, AusCann Group Holdings Ltd (ASX:AC8) announced that it had started harvesting its first medical cannabis crop in Chile through DayaCann, a joint venture between AusCann and the Daya Foundation, a non-profit based in Chile that advocates for alternative therapies.

Why these pot stocks smoked the ASX today

Why These Pot Stocks Smoked the ASX Today

It certainly has been a great day for pot stocks on the ASX. This morning Federal Health Minister Greg Hunt announced that the government would allow medical marijuana companies to distribute cannabis oils and medications in Australia within the next couple of months.

Cannabis in Australia: The Case Against Enthusiasm

Cannabis in Australia: The Case Against Enthusiasm

Gaelan Bloomfield and Ram Venkay, partners in a new investment fund that will be managed from Australia and will focus on Calif.-based cannabis investment opportunities, are notably wary about the prospects at home, Down Under.

MedLab LTD

Medlab and Aphria Complete Cannabis Supply Deal Ahead of Cannabis Human Trial

LEAMINGTON, Ontario, Aug. 22, 2016 /Weed Wire/ — Medical life science company, Medlab Clinical Limited (ASX:MDC), has signed a significant cannabis supply agreement with Canadian licenced producer of medical marijuana, Aphria Inc. (TSX VENTURE:APH)(OTCQB:APHQF).


Top